Enter a job title or keyword

Special Engineer, Cancer Immunotherapy


Job Location:

Oslo - Norway

Monthly Salary: Not provided by the employer
Posted: 4 September 2026 (14 days ago)
Application Deadline: 2 December 2026
Vacancies: 1 Vacancy

Job Summary


About the position

At the Unit for Translational Research Section of Cell Therapy Oslo University Hospital Radium Hospital a position is available for a Special Engineer with employment starting as soon as possible before the end of September 2026. Applicants must hold at least an MSc degree in Biology. The appointment is initially until 31 December 2026 with the possibility of extension.

The Section for Cell Therapy is a clinical section that houses one of Europes largest and most modern GMP facilities for cell products. The section also manufactures products for international industry-sponsored clinical trials. The section employs more than 40 staff members. The focus of its translational research activities is the development of novel cancer immunotherapies including the preclinical and clinical development and evaluation of improved cancer vaccines and adoptive cell therapies.
University Hospital is a workplace with great diversity. We believe this is crucial for solving our tasks in thebest possible way. We want this diversity to be reflected among the applicants for our positions and weencourage all qualified candidates regardless of background to apply!

Key information
Application deadline:
08.09.2026
Employer:
Oslo universitetssykehus HF
Town/city:
Oslo
Title:
Special Engineer
Positions:
1
Full-time/part-time:
Full-time
Employment type:
Contract
Percentage of full-time:
100
Webcruiter ID:
End date:
31.12.2026
Job description
The work associated with this position involves the processing of patient samples from participants enrolled in clinical trials evaluating novel cancer vaccines and other immunotherapies in both industry-sponsored and academic studies. The analyses include among other things the investigation of T-cell responses following immunotherapy treatment as well as the identification and characterisation of novel cancer antigens recognised by the patients immune system.
The successful candidate will receive samples from cancer patients isolate immune cells assess immune responses (cytokine response phenotype cytotoxicity) and conduct further research related to the immune system and biomarkers of treatment addition the role includes the establishment and documentation of laboratory procedures and methods as well as regular communication with study personnel involved in clinical trials. The employee will also be responsible for some aspects of laboratory operations and will contribute to research and the development of new therapeutic approaches.
Qualifications
  • Applicants must hold a qualification equivalent to an MSc degree in Biology.
  • Experience with primary T-cell culture ELISA or ELISPOT assays and flow cytometry is required.
  • Knowledge of Good Laboratory Practice (GLP) as well as experience working with patient samples or method validation is also essential.
  • Experience with transfection Western blot and microarray technology would be an advantage.

We are seeking a candidate who is accurate efficient responsible flexible and a strong communicator with the ability to work effectively as part of a team. Personal suitability and interpersonal skills will be given significant consideration.

Relevant documentation must be attached to the application.

We offer

We offer a secure workplace with a pleasant working environment supportive colleagues and a challenging position that provides a high degree of independence within a professionally stimulating and collaborative research environment.

Do you want to know more about us
Oslo universitetssykehus HF Radiumhospitalet Ullernchausseen 70 0379 Oslo Norway


Contacts
Else Marit Inderberg
Unit leader
Email:

About Company

Company Logo

Oslo University Hospital is a highly specialized hospital in charge of extensive regional and local hospital assignments. As Scandinavia’s largest hospital, we carry out more than 1.2 million patient treatments each year. The hospital has a nationwide responsibility for a number of na ... View more

View Profile View Profile